First Hawaiian Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

First Hawaiian Bank’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28	Closed	-$3K	–	1576
2019 Q1	$3K	Hold	28	–	–	﹤0.01%	1607
2018 Q4	$3K	Hold	28	–	–	﹤0.01%	1697
2018 Q3	$4K	Buy	+28	New	+$2.96K	﹤0.01%	1694

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Hawaiian Bank's ICPT Position: Q2 2019 in Review

First Hawaiian Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 28 shares — an estimated $3K sold.

First Hawaiian Bank first reported a position in ICPT in Q3 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.

First Hawaiian Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 28 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
First Hawaiian Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's Intercept Pharmaceuticals, Inc. position peaked at $4K in Q3 2018.
196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.